Formed as a spin-out from Massey Cancer Center at Virginia Commonwealth University, Light Switch Bio's team is working hard to develop the first photoactivated chemotherapy on the market. Firm's aim to minimize the risks of pharmaceuticals with laser-precision technologies for everyone, starting with patients.? Company Vision of Success: * For patients and payors, effective therapies with minimal risk of pharmaceutical or financial toxicity. * For healthcare providers, minimal risk of moral injury or scope creep derived from drug toxicity or complex procedures. * For pharma developers, revived marketability of effective drugs that failed or were underutilized due to toxicity.?
